About Index Trending news
Analyze
Top 50 Pricing
Protagonist Therapeutics

Protagonist Therapeutics

Work at Protagonist Therapeutics? Add yourself to this profile

Protagonist Therapeutics

Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$40,000,000
Foresite Capital, RA Capital Management, Starfish Ventures, +4
Venture capital (Series B)
$14,000,000
Employees

Unknown size

Locations
HQ
Headquarters
$40,000,000 Venture capital (Series C)
Xconomy

Protagonist Nabs $40M, Eyes 1st Trial Of Oral Peptide In Gut Disease

Health Funding